Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M400188-MCP200 on January 15, 2005.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow All Versions of this Article:
M400188-MCP200v1
M400188-MCP200v2
4/3/291    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sitek, B.
Right arrow Articles by Schramm, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sitek, B.
Right arrow Articles by Schramm, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 4:291-299, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Identification of Dynamic Proteome Changes Upon Ligand Activation of Trk-Receptors Using Two-dimensional Fluorescence Difference Gel Electrophoresis and Mass Spectrometry*

Barbara Sitek{ddagger}, Ognjan Apostolov{ddagger},§, Kai Stühler{ddagger}, Kathy Pfeiffer{ddagger}, Helmut E. Meyer{ddagger}, Angelika Eggert§ and Alexander Schramm§

From the {ddagger} Ruhr-University Bochum, Medical Proteom-Center, Universitaetsstr. 150, 44801 Bochum Germany; and § University Children’s Hospital of Essen, Division of Hematology/Oncology and Endocrinology, 45122 Essen, Germany

The TrkA and TrkB tyrosine kinases are members of the neurotrophin receptor family and mediate survival, differentiation, growth, and apoptosis of neurons in response to stimulation by their ligands, NGF and BDNF, respectively. Expression levels of TrkA/TrkB are important prognostic factors in a variety of embryonal tumors including neuroblastoma, the most common solid tumor of childhood. Because TrkA/TrkB exhibit a high level of sequence similarity and use overlapping pathways for signal transduction, the existence of specific effector molecules crucial for receptor and cell-type-specific response is likely. To identify these effectors by analyzing biological effects of TrkA and TrkB activation in a defined model, we performed a proteome study using the human neuroblastoma SY5Y cell line stably transfected with the TrkA or TrkB cDNA. The use of the recently introduced DIGE (fluorescence two-dimensional difference gel electrophoresis) system (Amersham Biosciences, Piscataway, NJ) allowed us to monitor differences in protein expression between samples in one gel. Proteomic changes were monitored in a time course of 0, 0.5, 1, 6, and 24 h following receptor activation. Using MALDI mass spectrometry, we identified, respectively, 22 and 9 differentially expressed proteins upon the addition of neurotrophin in SY5Y-TrkB and SY5Y-TrkA cells. Functional assignment revealed that the majority of these proteins are involved in organization and maintenance of cellular structures.


To whom correspondence should be addressed: University Hospital Essen, Children's Hospital, Division of Pediatric Oncology, Hufelandstrasse 55, 45122 Essen, Germany. Tel.: 49-201-723-2506; Fax: 49-201-723-5750; E-mail: alexander.schramm{at}uni-essen.de


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
E. Pewsey, C. Bruce, A. S. Georgiou, M. Jones, D. Baker, S. Y. Ow, P. C. Wright, C. K. Freberg, P. Collas, and A. Fazeli
Proteomics Analysis of Epithelial Cells Reprogrammed in Cell-free Extract
Mol. Cell. Proteomics, June 1, 2009; 8(6): 1401 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
Y. Hu, J. P. Malone, A. M. Fagan, R. R. Townsend, and D. M. Holtzman
Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid
Mol. Cell. Proteomics, December 1, 2005; 4(12): 2000 - 2009.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Hecht, J. H. Schulte, A. Eggert, J. Wilting, and L. Schweigerer
The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness
Carcinogenesis, December 1, 2005; 26(12): 2105 - 2115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement